Tumor Biomarker Test Market Report

Global Tumor Biomarker Test Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 11, 2022
  • PAGES：195
  • REPORT CODE：GMM809604
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Tumor Biomarker Test market report explains the definition, types, applications, major countries, and major players of the Tumor Biomarker Test market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Cancer Genetics Inc

    • Biocept Inc

    • Illumina Inc

    • Abbott Laboratories Inc

    • LabCorp Of America Holdings

    • Foundation Medicine Inc

    • Agilent Technologies

    • Danaher Corporation

    • AstraZeneca

    • Becton Dickinson & Co

    • NanoString Technologies Inc

    • Myriad Genetics Inc

    • Luminex Corporation

    By Type:

    • Prostate Specific Antigen Tests

    • CTC Tests

    • Alpha-Fetoprotein (AFP) Tests

    • CA Test

    • HER2 Tests

    • BRCA Test

    • Anaplastic Lymphoma Kinase (ALK) Tests

    • EGFR Mutation Tests

    • KRAS Test

    • Others

    By End-User:

    • Lung cancer

    • Breast cancer

    • Colorectal

    • Prostate Cancer

    • Blood Cancer

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Tumor Biomarker Test Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Tumor Biomarker Test Outlook to 2028- Original Forecasts

    • 2.2 Tumor Biomarker Test Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Tumor Biomarker Test Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Tumor Biomarker Test Market- Recent Developments

    • 6.1 Tumor Biomarker Test Market News and Developments

    • 6.2 Tumor Biomarker Test Market Deals Landscape

    7 Tumor Biomarker Test Raw Materials and Cost Structure Analysis

    • 7.1 Tumor Biomarker Test Key Raw Materials

    • 7.2 Tumor Biomarker Test Price Trend of Key Raw Materials

    • 7.3 Tumor Biomarker Test Key Suppliers of Raw Materials

    • 7.4 Tumor Biomarker Test Market Concentration Rate of Raw Materials

    • 7.5 Tumor Biomarker Test Cost Structure Analysis

      • 7.5.1 Tumor Biomarker Test Raw Materials Analysis

      • 7.5.2 Tumor Biomarker Test Labor Cost Analysis

      • 7.5.3 Tumor Biomarker Test Manufacturing Expenses Analysis

    8 Global Tumor Biomarker Test Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Tumor Biomarker Test Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Tumor Biomarker Test Export by Region (Top 10 Countries) (2017-2028)

    9 Global Tumor Biomarker Test Market Outlook by Types and Applications to 2022

    • 9.1 Global Tumor Biomarker Test Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Prostate Specific Antigen Tests Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CTC Tests Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Alpha-Fetoprotein (AFP) Tests Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global CA Test Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global HER2 Tests Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global BRCA Test Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global EGFR Mutation Tests Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global KRAS Test Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tumor Biomarker Test Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lung cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Breast cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Colorectal Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Blood Cancer Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Tumor Biomarker Test Market Analysis and Outlook till 2022

    • 10.1 Global Tumor Biomarker Test Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Tumor Biomarker Test Consumption (2017-2022)

      • 10.2.2 Canada Tumor Biomarker Test Consumption (2017-2022)

      • 10.2.3 Mexico Tumor Biomarker Test Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.2 UK Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.3 Spain Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.4 Belgium Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.5 France Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.6 Italy Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.7 Denmark Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.8 Finland Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.9 Norway Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.10 Sweden Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.11 Poland Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.12 Russia Tumor Biomarker Test Consumption (2017-2022)

      • 10.3.13 Turkey Tumor Biomarker Test Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.2 Japan Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.3 India Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.4 South Korea Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.5 Pakistan Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.6 Bangladesh Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.7 Indonesia Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.8 Thailand Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.9 Singapore Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.10 Malaysia Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.11 Philippines Tumor Biomarker Test Consumption (2017-2022)

      • 10.4.12 Vietnam Tumor Biomarker Test Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.2 Colombia Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.3 Chile Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.4 Argentina Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.5 Venezuela Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.6 Peru Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.7 Puerto Rico Tumor Biomarker Test Consumption (2017-2022)

      • 10.5.8 Ecuador Tumor Biomarker Test Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Tumor Biomarker Test Consumption (2017-2022)

      • 10.6.2 Kuwait Tumor Biomarker Test Consumption (2017-2022)

      • 10.6.3 Oman Tumor Biomarker Test Consumption (2017-2022)

      • 10.6.4 Qatar Tumor Biomarker Test Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Tumor Biomarker Test Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Tumor Biomarker Test Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Tumor Biomarker Test Consumption (2017-2022)

      • 10.7.2 South Africa Tumor Biomarker Test Consumption (2017-2022)

      • 10.7.3 Egypt Tumor Biomarker Test Consumption (2017-2022)

      • 10.7.4 Algeria Tumor Biomarker Test Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Tumor Biomarker Test Consumption (2017-2022)

      • 10.8.2 New Zealand Tumor Biomarker Test Consumption (2017-2022)

    11 Global Tumor Biomarker Test Competitive Analysis

    • 11.1 Cancer Genetics Inc

      • 11.1.1 Cancer Genetics Inc Company Details

      • 11.1.2 Cancer Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Cancer Genetics Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.1.4 Cancer Genetics Inc Tumor Biomarker Test Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Biocept Inc

      • 11.2.1 Biocept Inc Company Details

      • 11.2.2 Biocept Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Biocept Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.2.4 Biocept Inc Tumor Biomarker Test Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Illumina Inc

      • 11.3.1 Illumina Inc Company Details

      • 11.3.2 Illumina Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Illumina Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.3.4 Illumina Inc Tumor Biomarker Test Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Abbott Laboratories Inc

      • 11.4.1 Abbott Laboratories Inc Company Details

      • 11.4.2 Abbott Laboratories Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Abbott Laboratories Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.4.4 Abbott Laboratories Inc Tumor Biomarker Test Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 LabCorp Of America Holdings

      • 11.5.1 LabCorp Of America Holdings Company Details

      • 11.5.2 LabCorp Of America Holdings Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 LabCorp Of America Holdings Tumor Biomarker Test Main Business and Markets Served

      • 11.5.4 LabCorp Of America Holdings Tumor Biomarker Test Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Foundation Medicine Inc

      • 11.6.1 Foundation Medicine Inc Company Details

      • 11.6.2 Foundation Medicine Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Foundation Medicine Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.6.4 Foundation Medicine Inc Tumor Biomarker Test Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Agilent Technologies

      • 11.7.1 Agilent Technologies Company Details

      • 11.7.2 Agilent Technologies Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Agilent Technologies Tumor Biomarker Test Main Business and Markets Served

      • 11.7.4 Agilent Technologies Tumor Biomarker Test Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Danaher Corporation

      • 11.8.1 Danaher Corporation Company Details

      • 11.8.2 Danaher Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Danaher Corporation Tumor Biomarker Test Main Business and Markets Served

      • 11.8.4 Danaher Corporation Tumor Biomarker Test Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 AstraZeneca

      • 11.9.1 AstraZeneca Company Details

      • 11.9.2 AstraZeneca Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 AstraZeneca Tumor Biomarker Test Main Business and Markets Served

      • 11.9.4 AstraZeneca Tumor Biomarker Test Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Becton Dickinson & Co

      • 11.10.1 Becton Dickinson & Co Company Details

      • 11.10.2 Becton Dickinson & Co Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Becton Dickinson & Co Tumor Biomarker Test Main Business and Markets Served

      • 11.10.4 Becton Dickinson & Co Tumor Biomarker Test Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 NanoString Technologies Inc

      • 11.11.1 NanoString Technologies Inc Company Details

      • 11.11.2 NanoString Technologies Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 NanoString Technologies Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.11.4 NanoString Technologies Inc Tumor Biomarker Test Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Myriad Genetics Inc

      • 11.12.1 Myriad Genetics Inc Company Details

      • 11.12.2 Myriad Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Myriad Genetics Inc Tumor Biomarker Test Main Business and Markets Served

      • 11.12.4 Myriad Genetics Inc Tumor Biomarker Test Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Luminex Corporation

      • 11.13.1 Luminex Corporation Company Details

      • 11.13.2 Luminex Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Luminex Corporation Tumor Biomarker Test Main Business and Markets Served

      • 11.13.4 Luminex Corporation Tumor Biomarker Test Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Tumor Biomarker Test Market Outlook by Types and Applications to 2028

    • 12.1 Global Tumor Biomarker Test Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Prostate Specific Antigen Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global CTC Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Alpha-Fetoprotein (AFP) Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global CA Test Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global HER2 Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global BRCA Test Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global EGFR Mutation Tests Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global KRAS Test Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Tumor Biomarker Test Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Lung cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Breast cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Colorectal Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Tumor Biomarker Test Market Analysis and Outlook to 2028

    • 13.1 Global Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.2.2 Canada Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.2 UK Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.3 Spain Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.5 France Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.6 Italy Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.8 Finland Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.9 Norway Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.11 Poland Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.12 Russia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.2 Japan Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.3 India Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.3 Chile Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.6 Peru Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.6.3 Oman Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Tumor Biomarker Test Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Tumor Biomarker Test Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Tumor Biomarker Test Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Tumor Biomarker Test

    • Figure of Tumor Biomarker Test Picture

    • Table Global Tumor Biomarker Test Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Tumor Biomarker Test Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Prostate Specific Antigen Tests Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Tests Consumption and Growth Rate (2017-2022)

    • Figure Global Alpha-Fetoprotein (AFP) Tests Consumption and Growth Rate (2017-2022)

    • Figure Global CA Test Consumption and Growth Rate (2017-2022)

    • Figure Global HER2 Tests Consumption and Growth Rate (2017-2022)

    • Figure Global BRCA Test Consumption and Growth Rate (2017-2022)

    • Figure Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption and Growth Rate (2017-2022)

    • Figure Global EGFR Mutation Tests Consumption and Growth Rate (2017-2022)

    • Figure Global KRAS Test Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Lung cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Breast cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Colorectal Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Biomarker Test Consumption by Country (2017-2022)

    • Table North America Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure United States Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Canada Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Mexico Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table Europe Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure Germany Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure UK Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Spain Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Belgium Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure France Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Italy Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Denmark Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Finland Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Norway Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Sweden Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Poland Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Russia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Turkey Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table APAC Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure China Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Japan Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure India Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Thailand Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Singapore Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Philippines Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table South America Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure Brazil Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Colombia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Chile Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Argentina Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Peru Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table GCC Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure Bahrain Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Oman Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Qatar Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table Africa Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure Nigeria Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure South Africa Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Egypt Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure Algeria Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table Oceania Tumor Biomarker Test Consumption by Country (2017-2022)

    • Figure Australia Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Tumor Biomarker Test Consumption and Growth Rate (2017-2022)

    • Table Cancer Genetics Inc Company Details

    • Table Cancer Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cancer Genetics Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Cancer Genetics Inc Tumor Biomarker Test Product Portfolio

    • Table Biocept Inc Company Details

    • Table Biocept Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocept Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Biocept Inc Tumor Biomarker Test Product Portfolio

    • Table Illumina Inc Company Details

    • Table Illumina Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Illumina Inc Tumor Biomarker Test Product Portfolio

    • Table Abbott Laboratories Inc Company Details

    • Table Abbott Laboratories Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Laboratories Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Abbott Laboratories Inc Tumor Biomarker Test Product Portfolio

    • Table LabCorp Of America Holdings Company Details

    • Table LabCorp Of America Holdings Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table LabCorp Of America Holdings Tumor Biomarker Test Main Business and Markets Served

    • Table LabCorp Of America Holdings Tumor Biomarker Test Product Portfolio

    • Table Foundation Medicine Inc Company Details

    • Table Foundation Medicine Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foundation Medicine Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Foundation Medicine Inc Tumor Biomarker Test Product Portfolio

    • Table Agilent Technologies Company Details

    • Table Agilent Technologies Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Tumor Biomarker Test Main Business and Markets Served

    • Table Agilent Technologies Tumor Biomarker Test Product Portfolio

    • Table Danaher Corporation Company Details

    • Table Danaher Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Danaher Corporation Tumor Biomarker Test Main Business and Markets Served

    • Table Danaher Corporation Tumor Biomarker Test Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Tumor Biomarker Test Main Business and Markets Served

    • Table AstraZeneca Tumor Biomarker Test Product Portfolio

    • Table Becton Dickinson & Co Company Details

    • Table Becton Dickinson & Co Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Becton Dickinson & Co Tumor Biomarker Test Main Business and Markets Served

    • Table Becton Dickinson & Co Tumor Biomarker Test Product Portfolio

    • Table NanoString Technologies Inc Company Details

    • Table NanoString Technologies Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanoString Technologies Inc Tumor Biomarker Test Main Business and Markets Served

    • Table NanoString Technologies Inc Tumor Biomarker Test Product Portfolio

    • Table Myriad Genetics Inc Company Details

    • Table Myriad Genetics Inc Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Inc Tumor Biomarker Test Main Business and Markets Served

    • Table Myriad Genetics Inc Tumor Biomarker Test Product Portfolio

    • Table Luminex Corporation Company Details

    • Table Luminex Corporation Tumor Biomarker Test Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luminex Corporation Tumor Biomarker Test Main Business and Markets Served

    • Table Luminex Corporation Tumor Biomarker Test Product Portfolio

    • Figure Global Prostate Specific Antigen Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alpha-Fetoprotein (AFP) Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CA Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HER2 Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BRCA Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anaplastic Lymphoma Kinase (ALK) Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global EGFR Mutation Tests Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global KRAS Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Colorectal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Table North America Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure United States Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure Germany Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure China Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure Brazil Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Tumor Biomarker Test Consumption Forecast by Country (2022-2028)

    • Figure Australia Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Tumor Biomarker Test Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US